Collage photo of TCAF and Fennec Pharmaceuticals Inc/LinkedIn
May 21, 2024, 05:24
Kim Jones: Fennec Pharmaceuticals Inc and TCAF are working together to raise awareness of ototoxicity from Cisplatin
Kim Jones, CEO and Founder at Testicular Cancer Awareness Foundation, shared a post on LinkedIn:
“Cisplatin is a life-saving drug when it comes to the treatment of testicular cancer, but it has the potential to cause ototoxicity (hearing loss).
Fennec Pharmaceuticals Inc and Testicular Cancer Awareness Foundation (TCAF) are working together to raise awareness of ototoxicity and the options available to mitigate the possibility of hearing loss.
New episode of It Takes Balls out now!
Thank you Eric Meyer, Fennec Pharmaceuticals and Testicular Cancer Awareness Foundation.